help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muschel, R. J.
Right arrow Articles by Liotta, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muschel, R. J.
Right arrow Articles by Liotta, L. A.

American Journal of Pathology, Vol 121, 1-8, Copyright © 1985 by American Society for Investigative Pathology


REGULAR ARTICLES

Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell

RJ Muschel, JE Williams, DR Lowy and LA Liotta

NIH-3T3 cells and early passage fibroblasts transformed by various members of the rasH gene family were found to express metastatic potential in nude (Nu/Nu) mice. NIH-3T3 cells transformed by either the cloned DNA of the Harvey sarcoma virus or by the T24 human rasH oncogene were both tumorigenic after subcutaneous injection and metastatic after intravenous injection. In contrast, NIH-3T3 cells transformed by elevated levels of the proto-oncogene were tumorigenic but not metastatic. Tumor growth potential by itself, therefore, was not sufficient to induce metastatic behavior. Diploid fibroblasts transformed with the T24 rasH oncogene were tumorigenic and metastatic after intravenous injection and also produced extensive spontaneous metastases. Thus, induction of the complete metastatic phenotype by the T24 rasH oncogene does not require the use of aneuploid recipient cells such as NIH-3T3 cells. An alternative murine recipient cell type C127, when transformed by the cloned DNA of the Harvey sarcoma virus, was tumorigenic but not metastatic. The transformed C127 cells made less of the viral gene product P21 than the NIH-3T3 rasH transformants. To ensure that the decreased levels of P21 were not responsible for the lack of metastatic potential, C127 cells were transformed with altered constructs of the plasmid containing the Harvey sarcoma virus which elicited enhanced levels of P21. The augmented P21 levels, although equivalent to or greater than that seen in the NIH-3T3 transformants, did not confer metastatic potential on the C127 transformants. These results indicate that at least two complementation groups may be required for induction of metastatic capacity in this system, one involving the "activated" oncogenic form of the rasH gene and the second another as yet undefined factor in the cellular background present in NIH-3T3 cells but absent in C127 cells.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
P. O-charoenrat, I. Sarkaria, S. G. Talbot, P. Reddy, S. Dao, I. Ngai, A. Shaha, D. Kraus, J. Shah, V. Rusch, et al.
SCCRO (DCUN1D1) Induces Extracellular Matrix Invasion by Activating Matrix Metalloproteinase 2
Clin. Cancer Res., November 1, 2008; 14(21): 6780 - 6789.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H.-C. Chang, C.-Y. Cho, and W.-C. Hung
Silencing of the Metastasis Suppressor RECK by RAS Oncogene Is Mediated by DNA Methyltransferase 3b-Induced Promoter Methylation.
Cancer Res., September 1, 2006; 66(17): 8413 - 8420.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. H. van der Horst, Y. Y. Degenhardt, A. Strelow, A. Slavin, L. Chinn, J. Orf, M. Rong, S. Li, L.-H. See, K. Q. C. Nguyen, et al.
Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1
PNAS, November 1, 2005; 102(44): 15901 - 15906.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. J. Varghese, M. T. M. Davidson, I. C. MacDonald, S. M. Wilson, K. V. Nadkarni, A. C. Groom, and A. F. Chambers
Activated Ras Regulates the Proliferation/Apoptosis Balance and Early Survival of Developing Micrometastases
Cancer Res., February 1, 2002; 62(3): 887 - 891.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. W. Hunter, K. W. Broman, T. L. Voyer, L. Lukes, D. Cozma, M. T. Debies, J. Rouse, and D. R. Welch
Predisposition to Efficient Mammary Tumor Metastatic Progression Is Linked to the Breast Cancer Metastasis Suppressor Gene Brms1
Cancer Res., December 1, 2001; 61(24): 8866 - 8872.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
W. McKenna, K Nakahara, and R. Muschel
Site-specific integration of H-ras in transformed rat embryo cells
Science, September 9, 1988; 241(4871): 1325 - 1328.
[Abstract] [PDF]


Home page
ScienceHome page
J. Dennis, S Laferte, C Waghorne, M. Breitman, and R. Kerbel
Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis
Science, May 1, 1987; 236(4801): 582 - 585.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Society for Investigative Pathology.